Improvement in health-related quality of life after treatment with resmetirom in patients with the spectrum of MASLD: From early MASH to MASH cirrhosis

20261 citationsJournal Articlegold Open Access

Authors

Early MASH and MASH cirrhosis treated with resmetirom experience improvement in some disease-specific HRQL scores.

Published in: Hepatology Communications

Volume 10, Issue 3

Field-Weighted Citation Impact: 23.34